Wolverine Trading
TVRD

Wolverine Trading’s Tvardi Therapeutics TVRD Stock Holding History

Wolverine Trading’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-694
Closed -$18.6K – 5459
2023
Q4 		$18.6K Buy
694
+69
+11% +$2.86K ﹤0.01% 4376
2023
Q3 		$37.8K Sell
625
-269
-30% -$25.2K ﹤0.01% 4234
2023
Q2 		$91.8K Buy
+894
New +$123K ﹤0.01% 3799
2022
Q1 		– Sell
-558
Closed -$248K – 6664
2021
Q4 		$248K Buy
+558
New +$280K ﹤0.01% 4403
2021
Q3 		– Sell
-689
Closed -$358K – 7134
2021
Q2 		$358K Buy
689
+247
+56% +$157K ﹤0.01% 4171
2021
Q1 		$327K Buy
442
+81
+22% +$55.5K ﹤0.01% 4355
2020
Q4 		$200K Sell
361
-217
-38% -$114K ﹤0.01% 4227
2020
Q3 		$257K Sell
578
-214
-27% -$124K ﹤0.01% 3583
2020
Q2 		$478K Buy
792
+45
+6% +$24.9K ﹤0.01% 2780
2020
Q1 		$357K Sell
747
-397
-35% -$216K ﹤0.01% 3035
2019
Q4 		$676K Buy
1,144
+397
+53% +$279K ﹤0.01% 2790
2019
Q3 		$501K Sell
747
-575
-43% -$478K ﹤0.01% 2628
2019
Q2 		$1.02M Sell
1,322
-550
-29% -$386K ﹤0.01% 2017
2019
Q1 		$1.32M Buy
1,872
+511
+38% +$306K ﹤0.01% 1837
2018
Q4 		$622K Sell
1,361
-750
-36% -$484K ﹤0.01% 2428
2018
Q3 		$1.82M Buy
2,111
+928
+78% +$670K ﹤0.01% 1760
2018
Q2 		$527K Hold
1,183
– – ﹤0.01% 3026
2018
Q1 		$527K Buy
+1,183
New +$574K ﹤0.01% 3026

Other funds holding TVRD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Wolverine Trading's TVRD Position: Q3 2021 in Review

Wolverine Trading sold out of Tvardi Therapeutics (TVRD) in Q3 2021, closing a stake of 496 shares — an estimated $258K sold.

Wolverine Trading first reported a position in TVRD in Q1 2018 and held it in 13 quarters. The position peaked at $1.05M in Q1 2019. 168 funds tracked by Wall St. Rank hold TVRD as of Q3 2021.

  • Wolverine Trading reported no remaining Tvardi Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Wolverine Trading sold 496 Tvardi Therapeutics shares in Q3 2021, an estimated $258K.
  • Wolverine Trading first reported a position in Tvardi Therapeutics in Q1 2018 and held it in 13 quarters.
  • Wolverine Trading's Tvardi Therapeutics position peaked at $1.05M in Q1 2019.
  • 168 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2021.

Based on Wolverine Trading's 13F filing for Q3 2021, filed 12 Nov 2021.